David Hinds

David joined 23andMe in 2009. He leads the 23andMe statistical genetics group and works on understanding the role of genetics in disease and complex traits. Prior to 23andMe, he spent nine years at Perlegen Sciences as lead analyst for the company’s genome-wide polymorphism discovery projects and contributed to the International HapMap Project. David earned his PhD in Structural Biology from Stanford University having received a Howard Hughes Medical Institute predoctoral fellowship.